BioCentury
ARTICLE | Company News

Addrenex, Shionogi deal

November 23, 2009 8:00 AM UTC

Shionogi's Sciele Pharma Inc. subsidiary will acquire partner Addrenex for about $29 million in cash. Sciele already has rights to Addrenex's Clonicel clonidine to treat ADHD, Jenloga XR once-daily ...